Psychiatric symptoms are frequent in idiopathic intracranial hypertension patients

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
NEUROSURGICAL REVIEW, v.44, n.2, p.1183-1189, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Idiopathic intracranial hypertension (IIH) is a rare disease with an incidence rate of 0.5-2.0/100,000/year. Characteristic symptoms are headache and several degrees of visual impairment. Psychiatric symptoms in association with IIH are usually poorly described and underestimated. In this study, we evaluated IIH subjects to determine the association with psychiatric symptoms. We evaluated thirty consecutive patients with IIH submitted to neurosurgery from January 2017 to January 2020 in two Brazilian tertiary hospitals. They underwent clinical evaluation, obtaining medical history, comorbidities, body mass index (BMI-kg/m(2)), and applying Neuropsychiatric Inventory Questionnaire (NPI-Q). There were 28 females and 2 males. Ages ranged from 18 to 66 years old, with mean age of 37.97 +/- 12.78. Twenty-five (83%) presented comorbidities, being obese and having arterial hypertension the most frequent. Body mass index ranged from 25 to 35 kg/m(2)and mean value was 31 +/- 3.42. After application of Neuropsychiatric Interview, 26 of 30 presented psychiatric symptoms (86%). Depression-anxiety syndromes were reported in 25 patients (83%). Nighttime disturbances were reported by 14 subjects (46%). Appetite and eating disorders were described by 23 (76%). Psychiatric symptoms in association with IIH are usually poorly described and underestimated. In our sample, twenty-six out of 30 (86%) reported psychiatric symptoms. We highlight the high prevalence of psychiatric symptoms among IIH patients and the need of managing these patients with a multidisciplinary team, including psychiatrists.
Palavras-chave
Intracranial idiopathic hypertension, Psychiatry, Symptoms, Neurosurgery
Referências
  1. Bruce BB, 2016, NEUROLOGY, V87, P1871, DOI 10.1212/WNL.0000000000003280
  2. Camozzato AL, 2008, INT PSYCHOGERIATR, V20, P383, DOI 10.1017/S1041610207006254
  3. Camozzato AL, 2015, ARQ NEURO-PSIQUIAT, V73, P41, DOI 10.1590/0004-282X20140177
  4. CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308
  5. Duggal HS, 2005, J NEUROPSYCH CLIN N, V17, P426, DOI 10.1176/appi.neuropsych.17.3.426
  6. Friedman Deborah I, 2013, Neurology, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17
  7. Giridharan N, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.4.FOCUS18100
  8. GIUSEFFI V, 1991, NEUROLOGY, V41, P239, DOI 10.1212/WNL.41.2_Part_1.239
  9. Gurney SP, 2020, EYE BRAIN, V12, P1, DOI 10.2147/EB.S193027
  10. Hoffmann J, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0919-2
  11. Kalyvas A, 2021, NEUROSURG REV, V44, P773, DOI 10.1007/s10143-020-01288-1
  12. Kaplan CP, 1997, BRAIN INJURY, V11, P293, DOI 10.1080/026990597123601
  13. Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233
  14. Kesler A, 2005, ISRAEL MED ASSOC J, V7, P627
  15. Kleinschmidt JJ, 2000, NEUROLOGY, V54, P319, DOI 10.1212/WNL.54.2.319
  16. Krakowski AC, 2007, PEDIATR ANN, V36, P145, DOI 10.3928/0090-4481-20070301-05
  17. Kuzman MR, 2008, PSYCHIAT CLIN NEUROS, V62, P367, DOI 10.1111/j.1440-1819.2008.01810.x
  18. Lai CKY, 2014, CLIN INTERV AGING, V9, P1051, DOI 10.2147/CIA.S63504
  19. Mitchell JL, 2019, CURR OPIN NEUROL, V32, P422, DOI 10.1097/WCO.0000000000000690
  20. Mollan SP, 2018, J NEUROL NEUROSUR PS, V89, P1088, DOI 10.1136/jnnp-2017-317440
  21. Mollan Susan P, 2018, Pract Neurol, V18, P485, DOI 10.1136/practneurol-2018-002009
  22. Mollan SP, 2016, J NEUROL NEUROSUR PS, V87, P982, DOI 10.1136/jnnp-2015-311302
  23. Mulla Y, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0521-9
  24. Oliveira MF, 2014, ARQ NEURO-PSIQUIAT, V72, P435, DOI 10.1590/0004-282X20140047
  25. Piper RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003434.pub3
  26. Puustinen T, 2019, CLIN NEUROL NEUROSUR, V186, DOI 10.1016/j.clineuro.2019.105527
  27. Raggi A, 2018, NEUROL SCI, V39, pS139, DOI 10.1007/s10072-018-3361-y
  28. Salzbrenner Stephen, 2009, Psychiatry (Edgmont), V6, P29
  29. SORENSEN PS, 1986, ACTA NEUROL SCAND, V73, P264
  30. Yri HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004376
  31. Zur D, 2015, J NEURO-OPHTHALMOL, V35, P26, DOI 10.1097/WNO.0000000000000199